CSPP1
protein-codingcentrosome and spindle pole associated protein 1
Gene summary
This gene encodes a centrosome and spindle pole associated protein. The encoded protein plays a role in cell-cycle progression and spindle organization, regulates cytokinesis, interacts with Nephrocystin 8 and is required for cilia formation. Mutations in this gene result in primary cilia abnormalities and classical Joubert syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~134.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014288
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0018921
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018772
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014288
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0018342
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014288
Submitter: ClinGen
CSPP1 was first reported in relation to autosomal-recessive classical Joubert Syndrome (JBTS) with or without Jeune asphyxiating thoracic dystrophy (JATD) in 28 individuals, and with a Meckel Syndrome (MKS)-like phenotype in 2 individuals from a single family, in three back-to-back publications in 2014 (Akizu et al., PMID:24360807; Tuz et al., PMID:24360808; Shaheen et al., PMID: 24360803). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanisms AND/OR inheritance pattern AND/OR phenotypic variability. Therefore, the three disease entities have been lumped into one disease entity, Joubert Syndrome 21 (OMIM:615636). There are 31 null variants (variant types: 9 nonsense, 6 splice site, 16 frameshift) that have been reported in >30 probands in at least 7 publications (PMIDs 24360807, 24360808, 24360803, 32386258, 26092869, 27434533, 31980526) and are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be biallelic loss of function. This gene-disease association is also supported by experimental evidence e.g. zebrafish-morpholino, expression studies, and in vitro functional assays with primary patient cells (dermal fibroblasts) (PMIDs 24360807, 24360808, 24360803). Renal involvement in terms of hyperechogenic (oligocystic) kidneys was reported infrequently in a minority of patients (about 3/30). In summary, CSPP1 is definitively associated with a spectrum of autosomal-recessive ciliopathy phenotypes. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy GCEP on the meeting date 6/23/2021 (SOP Version 8).
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Mild sensorineural hearing loss has been described in several individuals
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CSPP1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001382391.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 227 | 2 | 234 | ||
| missense | 1 | 516 | 32 | 1 | 550 | |
| nonsense | 22 | 17 | 5 | 44 | ||
| start loss | 0 | |||||
| frameshift | 42 | 30 | 10 | 82 | ||
| splice donor/acceptor (+/-2bp) | 9 | 22 | 8 | 2 | 41 | |
| Total | 73 | 70 | 544 | 261 | 3 | 951 |
Highest pathogenic variant AF is 0.00012919896
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001369320.1 | 30 | MANE Select | |
| Ensembl | ENSP00000504733.1 | 30 | MANE Select | |
| RefSeq | NP_001278268.1 | 23 | Standard | |
| RefSeq | NP_001350060.1 | 29 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cspp1a | Danio rerio | Structure: pronephros Quality: cystic abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- positive regulation of cytokinesis
- positive regulation of cell division
Cellular Component
- spindle pole
- cytoplasm
- centrosome
- spindle
- microtubule
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000262210
- Coding exons
- 29
- Length
- 133838
- Individuals with no LoFs
- 124581
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 220
- Defined
- 124801
- p
- 0.000882
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.654 | 601 | 648 | 0.928 | 0.0000342 | 8060 |
| Missense (PolyPhen) | 171 | 206.79 | 0.82694 | 2662 | ||
| Synonymous | -0.0213 | 218 | 218 | 1.00 | 0.0000109 | 2204 |
| Loss of Function | 2.04 | 55 | 73.9 | 0.744 | 0.00000430 | 878 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00066 | 0.00065 | rare |
| Latino/Admixed American | 0.0010 | 0.0010 | notable |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0022 | 0.0021 | notable |
| Finnish | 0.00019 | 0.00019 | rare |
| European (Non-Finnish) | 0.00088 | 0.00087 | rare |
| South Asian | 0.0011 | 0.0010 | notable |
| Other | 0.00066 | 0.00066 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May play a role in cell-cycle-dependent microtubule organization. {ECO:0000269|PubMed:16826565}.;
- Disease
- DISEASE: Joubert syndrome 21 (JBTS21) [MIM:615636]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly. {ECO:0000269|PubMed:24360803, ECO:0000269|PubMed:24360807, ECO:0000269|PubMed:24360808}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.953
- RVIS EVS
- -0.26
- RVIS percentile EVS
- 34.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.204
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |